KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Acceptance of late-breaking abstract of PNOC022 data, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 65 Posts.
    lightbulb Created with Sketch. 16
    I love paxalisib, evt801 has real potential. You need to keep everyone aligned with how trials are progressing. The fallacy that is spread around 'it's great that they aren't reporting on time, as patients are living longer' is just that; a fallacy! Look at the primary and secondary outcome milestones on clinicaltrials.org, once a patient meets the 6 month milestone of dfp the patient data can be reported. If they live dfp longer that is amazing and quite probably happening. I think the drugs have real potential, having lost loved ones to cancer I want to see drugs were they need to be. Management 101: under promise over deliver! DIPG data that was promised by Dr. Friend in July then Aug, then Sept and all we get is an abstract with no data...does anyone want to put potential life saving drugs in the hands of this team???
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.